Compounds > agreal
Page last updated: 2024-08-23

agreal and Basal Ganglia Diseases

agreal has been researched along with Basal Ganglia Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andréjak, M; Geslin, JM; Gras-Champel, V; Lemaire-Hurtel, AS; Masmoudi, K; Masson, H; Munier, A1
De Leo, V; Delia, A; Faldini, E; Morgante, G; Musacchio, MC; Petraglia, F1

Reviews

1 review(s) available for agreal and Basal Ganglia Diseases

ArticleYear
The safety of veralipride.
    Expert opinion on drug safety, 2006, Volume: 5, Issue:5

    Topics: Adult; Aged; Basal Ganglia Diseases; Dopamine D2 Receptor Antagonists; Estrogens; Female; Half-Life; Hot Flashes; Humans; Middle Aged; Parkinsonian Disorders; Randomized Controlled Trials as Topic; Risk Assessment; Safety; Sulpiride

2006

Other Studies

1 other study(ies) available for agreal and Basal Ganglia Diseases

ArticleYear
[Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].
    La Revue de medecine interne, 2005, Volume: 26, Issue:6

    Topics: Aged; Akathisia, Drug-Induced; Basal Ganglia Diseases; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Sulpiride

2005